Influence of COVID-19 on the cardiovascular system
Keywords:
COVID-19, cardiovascular diseases, myocardial damageAbstract
Introduction: the incidence of coronavirus-2 infection, which causes the infectious illness known as COVID-19, has affected populations worldwide. Objective: to collate available evidence regarding the influence of COVID-19 on the cardiovascular system. Method: at the General Teaching Hospital "Dr. Agostinho Neto", between March and June 2020 a narrative review was made on this topic through a search in different bibliographic databases: Pubmed/Medline, ScienceDirect and SciELO. Results: the information was structured in general aspects of this disease, cardiovascular manifestations, implications of interaction between cardiovascular drugs and those used to treat the infection, prognosis and natural history of the patient from the cardiovascular perspective. The following needs were identified: to determine the effectiveness of treatments for patients with comorbidities, to investigate the influence of treatment on the genesis of myocardial damage and the drugs that prevent it, to clarify the natural history of the survivors, to determine the relationship between viral load and cardiac manifestations, among others. Conclusions: the clinical condition of patients with this condition may be impaired by the presence of myocardial damage, but the pathophysiological basis of how SARS-CoV-2 generates this is not clear. Its appearance and the history of cardiovascular disease adversely affect the prognosis of the patient, which legitimizes the need for professional preparation to be able to make an accurate assessment of the cardiovascular system for the prevention and control of this complication.
Downloads
References
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. Apneumonia outbreak associated with a new coronavirus of probablebat origin. Nature [en línea]. 2020 Mar [citado 9 Jun 2020]; 579(7798):270-273. Doi: https://doi.org/10.1038/s41586-020-2012-7
World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 [en línea]. 2020 [citado 9 Jun 2020]. Disponible en: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020
World Health Organization. Coronavirus disease 2019 (COVID-19). Situation Report, 101 [en línea]. 2020 [citado 9 Jun 2020]. Disponible en: https://apps.who.int/iris/hanjdle/10665/332054
Cuba. Ministerio de Salud Pública. Parte de cierre del día 22 de marzo de 2020 a las 12 de la noche [en línea]. 2020 [citado 9 Jun 2020]. Disponible en: https://salud.msp.gob.cu/?p=5681
Naranjo DA, Valdés MA. COVID-19. Punto de vista del cardiólogo. Rev Cubana Card Cir Cardiov [en línea]. 2020 Mar [citado 9 Jun 2020]; 26(1):1-5. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/951/pdf
Moreno MFL, Moreno LFL, Oroz MR. Repercusión cardiovascular de la infección por el nuevo coronavirus SARS-CoV-2 (COVID-19). Cor Salud [en línea]. 2020 [citado 9 Jun 2020]; 12(1):3-17. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/downloadview/588/1112
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med [en línea]. 2020 [citado 9 Jun 2020]; 26:450-455. Doi: https://doi.org/10.1038/s41591-020-0820-9
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med [en línea]. 2020 [citado 9 Jun 2020]; 382(2019):727–733. Doi: https://doi.org/doi:10.1056/NEJMoa2001017
Wu P, Hao X, Lau EHY, Wong JY, Leung KSM, Wu JT, et al. Real time tentative assesment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January, 2020. Euro Surveill [en línea]. 2020 [citado 9 Jun 2020]; 25(3):pii2000044. Doi: https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000044
Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. Coronavirus disease 2019 (COVID-19) cardiovascular disease. Circulation [en línea]. 2020 [citado 9 Jun 2020]; 141:1648-1655. Doi: http://doi.org/10.1161/CIRCULATIONAHA.120.046941
Palacios CM, Santos E, Velázquez CMA, León JM. COVID-19 una emergencia de salud pública mundial. Rev Clin Esp [en línea]. 2020 [citado 9 Jun 2020]; 1885:[aprox. 7 p.]. Doi: https://doi.org/10.1016/j.rce.2020.03.001
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res [en línea]. 2020 [citado 9 Jun 2020]; 7(11):1-10. Doi: https://doi.org/10.1186/s40779-020-00240-0
Matsushita K, Marchandot B, Jesel L, Ohlmann P, Morel O. Impact of COVID-19 on the Cardiovascular System: A Review. J Clin Med [en línea]. 2020 [citado 9 Jun 2020]; 9(5):1407. Doi: https://doi.org/10.3390/jcm9051407
Sociedad Interamericana de Cardiología. Coronavirus y su impacto cardiovascular [en línea] 2020 [citado 9 Jun 2020]. Disponible en: http://www.siacardio.com/novedades/covid-19/coronavirus-y-su-impacto-cardiovascular/
Rothan HA, Siddappa NB. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoim [en línea]. 2020 May [citado 9 Jun 2020]; 109:102433. Doi: 10.1016/j.jaut.2020.102433
Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J [en línea]. 2020 [citado 9 Jun 2020]; 41(19):1798-1800. Doi: https://doi.org/10.1093/eurheartj/ehaa231
Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute syndrome coronavirus 2 infection. JAHA [en línea]. 2020 Apr [citado 9 Jun 2020]; 9(7):e016219. Doi: https://doi.or/10.1161/JAHA.120.016219
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intens Care Med [en línea]. 2020 Apr [citado 9 Jun 2020]; 46(5):846-848. Doi: https://doi.org/10.1007/s00134-020-05991-x
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. 2019 Lancet [en línea]. 2020 [citado 9 Jun 2020]; 395(10223):497-506. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(20)30183-5
García SA. Revisión narrativa sobre la respuesta inmunitaria frente a coronavirus: descripción general, aplicabilidad para SARS-COV-2 e implicaciones terapéuticas. An Pediatr (Barc) [en línea]. 2020 Jul [citado 9 Jun 2020]; 93(1):60.e1–60.e7. Doi: 10.1016/j.anpedi.2020.04.016
Bonow RO, Fonarow GC, O'Gara PT, Yancy CW. Association of Coronavirus Disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol [en línea]. 2020 Mar [citado 9 Jun 2020]. Doi: http://doi.org/10.1001/jamacardio.2020.1105
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol [en línea]. 2020 [citado 9 Jun 2020]; 17:259-260. Doi: http://doi.org/10.1038/s41569-020-0360-5
Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J [en línea]. 2020 [citado 9 Jun 2020]. Doi: https://doi.org/10.1093/eurheartj/ehaa190
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med [en línea]. 2020 May [citado 9 Jun 2020]; 382:1708-1720. Doi: http://dx.doi.org/10.1056/NEJMoa2002032
Nunes KA, Tagliari AP, Battista FG, Michele FG, Tondo C. Cardiac and arrhythmic complications in patients with COVID‐19. J Cardiov Electrophysiol [en línea]. 2020 May [citado 9 Jun 2020]; 31(5):1003-1008. Doi: https://doi.org/10.1111/jce.14479
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China. JAMA [en línea]. 2020 [citado 9 Jun 2020]; 323(11):1061-1069. Doi: https://doi.org/10.1001/jama.2020.1585
García FMA, Gómez de Diego JJ. COVID-19 y afectación cardíaca. Rev Chil Anest [en línea]. 2020 Mar [citado 9 Jun 2020]; 49:397-400. Doi: https://doi.org/10.25237/revchilanestv49n03.018
Kobayashi T, Jung SM, Linton NM, Kinoshita R, Hayashi K, Miyama T, et al. Communicating the risk of death from novel coronavirus disease (COVID-19). J Clin Med [en línea]. 2020 Feb. [citado 9 Jun 2020]; 9(2):580. Doi: https://doi.org/10.3390/jcm9020580
Madjid M, Safavi NP, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol [en línea]. 2020 Mar [citado 9 Jun 2020]. [10 p.]. Doi: https://doi.org/10.1001/jamacardio.2020.1286
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of a dultin patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [en línea]. 2020 [citado 9 Jun 2020]; 395:1054–1062. Doi: https://doi.org/10.1016/S0140-6736(20)30566-3
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: asingle-centered, retrospective, observational study. Lancet Respir Med [en línea]. 2020 Feb [citado 9 Jun 2020]; 8(5):475-481. Doi: https://doi.org/10.1016/S2213-2600(20)30079-5
Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Netw Open [en línea]. 2020 Mar [citado 9 Jun 2020]; 3(4);[aprox. 6 p.]. Disponible en: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2764293
Obregón SAG, Adolfo PJ, Pérez BA, Vila GEE. Insuficiencia cardíaca aguda en época de COVID-19. Rev Cubana Cardiol Cir Cardiov [en línea]. 2020 [citado 9 Jun 2020]; 26(2):1-13. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/995/pdf
Rao S, Sasser W, Díaz F, Sharma N, Alten J. Coronavirus associated fulminant myocarditis successfully treated with intravenous inmunoglobulin and extracorporeal membrane oxygenation. Chest [en línea]. 2020 Apr [citado 9 Jun 2020]; 146(4):336A. Disponible en: https://europepmc.org/abstract/med/25334353
García HAR, Rivero SSL, Aroche AR, Aldama PLI, Hernández NM. COVID-19: en torno al sistema cardiovascular. Anales Acad Ciencias Cuba [en línea]. 2020 Abr [citado 9 Jun 2020]; 10(2):1-7. Disponible en: http://www.revistaccuba.sld.cu/index.php/revacc/article/view/782/821
Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J [en línea]. 2020 [citado 9 Jun 2020]; 41(19):1858-1159. Doi: https://doi.org/10.1093/eurheartj/ehaa254
Deepak A, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the Cardiologist. Basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies. JACC: Basic To Translational Science [en línea]. 2020 May [citado 9 Jun 2020]; 5(5):518-536. Doi: https://doi.org/10.1016/j.jacbts.2020.04.002
Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med [en línea]. 2020 [citado 9 Jun 2020]; 382(17):e38. Doi: https://doi.org/10.1056/nejmc2007575
Gauna ME, Bernava JL. Recomendaciones diagnósticas y terapéuticas ante la Respuesta Inmune Trombótica Asociada a Covid-19 (RITAC). CorSalud [en línea]. 2020 [citado 9 Jun 2020]; 12(1):60-63. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/615/1110
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [en línea]. 2020 [citado 9 Jun 2020]; 395:507-13. Doi: http://dx.doi.org/10.1016/S0140-6736(20)30211-7
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res [en línea]. 2020 [citado 9 Jun 2020]; 7(1):11-12. Doi: https://doi.org/10.1186/s40779-020-00240-0
López PJJD, Ponce de León PA, Cárdenas MPA, Giraldo GGC, Herrera EA. Coronavirus – COVID 19: Más allá de la enfermedad pulmonar, qué es y qué sabemos del vínculo con el sistema cardiovascular. Rev Colom Cardiol [en línea]. 2020 Abr [citado 9 Jun 2020]; 21(2):S0120-5633. Doi: https://doi.org/doi:10.1016/j.rccar.2020.04.006
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Reinaldo Elias-Sierra, Karla Sucet Elias-Armas, Fabianne González-Tirado, Eglys Maceo-Sobrado
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Gaceta Médica Estudiantil magazine provides immediate Open Access to its content. It is published under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC) license, which allows sharing (copying and redistributing the material in any medium or format) and adapting (remixing, transforming, and building upon the material), under the terms of acknowledge authorship and not make commercial use of the materials.
